TSHA
Price
$4.14
Change
-$0.35 (-7.80%)
Updated
Oct 12 closing price
Capitalization
1.63B
28 days until earnings call
Intraday BUY SELL Signals
VIR
Price
$11.30
Change
-$0.40 (-3.42%)
Updated
Oct 12 closing price
Capitalization
1.78B
16 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

TSHA vs VIR

TSHA vs VIR Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
TSHA vs. VIR commentary
Oct 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TSHA is a Buy and VIR is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
TSHA vs VIR: Fundamental Ratings
TSHA
VIR
OUTLOOK RATING
1..100
1168
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
56
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9896
PRICE GROWTH RATING
1..100
7637
P/E GROWTH RATING
1..100
9822
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VIR's Valuation (56) in the null industry is in the same range as TSHA (61). This means that VIR’s stock grew similarly to TSHA’s over the last 12 months.

VIR's Profit vs Risk Rating (100) in the null industry is in the same range as TSHA (100). This means that VIR’s stock grew similarly to TSHA’s over the last 12 months.

VIR's SMR Rating (96) in the null industry is in the same range as TSHA (98). This means that VIR’s stock grew similarly to TSHA’s over the last 12 months.

VIR's Price Growth Rating (37) in the null industry is somewhat better than the same rating for TSHA (76). This means that VIR’s stock grew somewhat faster than TSHA’s over the last 12 months.

VIR's P/E Growth Rating (22) in the null industry is significantly better than the same rating for TSHA (98). This means that VIR’s stock grew significantly faster than TSHA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TSHAVIR
RSI
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 6 days ago
67%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
80%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 21 days ago
81%
Bullish Trend 12 days ago
75%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 5 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
COMPARISON
Comparison
Oct 13, 2026
Stock price -- (TSHA: $4.14 vs. VIR: $11.30)
Brand notoriety: TSHA and VIR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TSHA: 74% vs. VIR: 45%
Market capitalization -- TSHA: $1.63B vs. VIR: $1.78B
TSHA [@Biotechnology] is valued at $1.63B. VIR’s [@Biotechnology] market capitalization is $1.78B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TSHA’s FA Score shows that 0 FA rating(s) are green while VIR’s FA Score has 1 green FA rating(s).

  • TSHA’s FA Score: 0 green, 5 red.
  • VIR’s FA Score: 1 green, 4 red.
According to our system of comparison, VIR is a better buy in the long-term than TSHA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TSHA’s TA Score shows that 4 TA indicator(s) are bullish while VIR’s TA Score has 4 bullish TA indicator(s).

  • TSHA’s TA Score: 4 bullish, 3 bearish.
  • VIR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, TSHA is a better buy in the short-term than VIR.

Price Growth

TSHA (@Biotechnology) experienced а -7.80% price change this week, while VIR (@Biotechnology) price change was -4.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.09%. For the same industry, the average monthly price growth was -11.53%, and the average quarterly price growth was -11.77%.

Reported Earning Dates

TSHA is expected to report earnings on Nov 10, 2026.

VIR is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Biotechnology (-5.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
TSHA
Daily Signal:
Gain/Loss:
VIR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AGRO10.300.06
+0.59%
Adecoagro SA
PFE28.400.12
+0.42%
Pfizer
COSO26.780.11
+0.41%
CoastalSouth Bancshares Inc
TXNM58.42-0.19
-0.32%
TXNM Energy Inc
VTIX0.99-0.08
-7.48%
Virtuix Holdings Inc

TSHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TSHA has been loosely correlated with SLDB. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if TSHA jumps, then SLDB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSHA
1D Price
Change %
TSHA100%
-7.80%
SLDB - TSHA
50%
Loosely correlated
-2.33%
MGTX - TSHA
50%
Loosely correlated
-2.90%
ABEO - TSHA
49%
Loosely correlated
-0.81%
STOK - TSHA
49%
Loosely correlated
-2.38%
VIR - TSHA
47%
Loosely correlated
-3.42%
More

VIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIR has been loosely correlated with BEAM. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if VIR jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIR
1D Price
Change %
VIR100%
-3.42%
BEAM - VIR
55%
Loosely correlated
-2.22%
DNLI - VIR
52%
Loosely correlated
-2.57%
PRME - VIR
52%
Loosely correlated
-9.52%
EDIT - VIR
52%
Loosely correlated
-5.17%
RCUS - VIR
51%
Loosely correlated
-0.29%
More